Tag: ACCESS

Blog Posts (6)

August 18, 2014

When unapproved drugs are the only help: A case for compassionate use

[CNBC] wo years ago, Nathalie Traller spent her days like any seventh-grader might. She played soccer and swam and studied for classes. Then Nathalie started getting bad headaches, the kind that made it hard for her to concentrate. A trip to the doctor revealed the unthinkable: a mass the size of a baseball in her […]
July 10, 2014

Hensinki Declaration revisions weaken protections for developing country trial participants

The latest revisions to the Declaration of Helsinki may weaken human research subject protections, particularly for participants in low and middle income countries, according to a recent analysis in BMJ.  See the article here:  http://www.bmj.com/content/349/bmj.g4254
July 8, 2014

Merck Says It Regrets Strong-Arming Italian Researcher

[Forbes] Merck says that it “regrets” using legal threats to push a leading Italian researcher to muffle his public critiques of one of the company’s cholesterol drugs. Merck spokesman Steve Cragle writes: Merck is committed to the open and transparent exchange of scientific information. We believe this exchange should take place in medical meetings and […]
July 1, 2014

Supreme Court Rejects Contraceptives Mandate for Some Corporations

[The New York Times]  The Supreme Court ruled on Monday that requiring family-owned corporations to pay for insurance coverage for contraception under the Affordable Care Act violated a federal law protecting religious freedom. It was, a dissent said, “a decision of startling breadth.” The 5-to-4 ruling, which applied to two companies owned by Christian families, opened the door […]
June 24, 2014

Pharmaceutical firms find it hard to exit essential drugs market

[TheEconomicTimes] Pharmaceutical companies having more than a 1% market share for any essential drugs may find it difficult to stop manufacturing those products. Since May, when the government brought into force a new drug-pricing system after a gap of 18 years, the National Pharmaceutical Pricing Authority has denied such requests whenever the market share of […]
June 23, 2014

Teen Suicide Attempts Rise as Warning Cuts Medicine Use

[Bloomberg] A widely publicized warning by U.S. regulators a decade ago about risks for teenagers taking antidepressants led to plummeting prescriptions and increased suicide attempts, Harvard University researchers said. As the public took the Food and Drug Administration’s 2004 warning to heart, adolescent attempted suicides increased 21.7 percent and a 31 percent decline in antidepressant […]